Stevanato Group S.p.A (STVN) Depreciation & Amortization (CF) (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Depreciation & Amortization (CF) of $25.0 million for Q1 2026, up 38.97% year-over-year from $18.0 million in Q1 2025, and up 1.7% quarter-over-quarter from $24.6 million in Q4 2025.
Stevanato Group S.p.A (STVN) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $25.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 38.97% year-over-year to $25.0 million; the TTM figure through Mar 2026 stood at $91.8 million (up 32.59% YoY), while the FY2025 annual figure was $87.2 million, up 25.13% from the prior year.
- Depreciation & Amortization (CF) improved to $25.0 million in Q1 2026 per STVN's latest filing, from $24.6 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $25.0 million in Q1 2026 and bottomed at $13.1 million in Q3 2022.
- Historically, Depreciation & Amortization (CF) has averaged $17.7 million across 5 years, with a median of $17.1 million in 2023.
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) slipped 11.11% — and 2025, when it soared 45.64%.
- Stevanato Group S.p.A's Depreciation & Amortization (CF) stood at $13.6 million in 2022, then grew by 24.85% to $17.0 million in 2023, then declined by 0.64% to $16.9 million in 2024, then jumped by 45.64% to $24.6 million in 2025, then climbed by 1.7% to $25.0 million in 2026.
- Business Quant data shows STVN's Depreciation & Amortization (CF) at $25.0 million in Q1 2026, $24.6 million in Q4 2025, and $21.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 24.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.51 Mn |
| Jun 30, 2026 | 24.51 Mn |
| Mar 31, 2026 | 25.02 Mn |
| Mar 31, 2026 | 25.02 Mn |
| Dec 31, 2025 | 24.60 Mn |
| Dec 31, 2025 | 24.60 Mn |
| Sep 30, 2025 | 21.37 Mn |
| Sep 30, 2025 | 21.37 Mn |
| Jun 30, 2025 | 20.82 Mn |
| Jun 30, 2025 | 20.82 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Dec 31, 2024 | 16.89 Mn |
| Dec 31, 2024 | 16.89 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Jun 30, 2024 | 18.24 Mn |
| Jun 30, 2024 | 18.24 Mn |
| Mar 31, 2024 | 19.35 Mn |
| Mar 31, 2024 | 19.35 Mn |